Armata Pharmaceuticals, Inc.
ARMP
$1.42
$0.06815.04%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -58.46% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -58.46% | -- | |||
| Cost of Revenue | 10,342.11% | -96.19% | |||
| Gross Profit | -1,326.15% | 131.27% | |||
| SG&A Expenses | 2.44% | -5.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.50% | 6.84% | |||
| Operating Income | -8.03% | 18.11% | |||
| Income Before Tax | 147.44% | -160.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 147.44% | -160.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 147.44% | -160.99% | |||
| EBIT | -8.03% | 18.11% | |||
| EBITDA | -7.58% | 18.59% | |||
| EPS Basic | 147.46% | -160.97% | |||
| Normalized Basic EPS | -10.57% | 14.13% | |||
| EPS Diluted | -245.94% | 38.76% | |||
| Normalized Diluted EPS | 32.30% | -38.36% | |||
| Average Basic Shares Outstanding | 0.01% | 0.07% | |||
| Average Diluted Shares Outstanding | 63.30% | -37.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||